Translation and Validation of the Hypoparathyroidism Patient Experience Scales (HPES) Questionnaire in Greek

NCT07160348 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-09-08

No results posted yet for this study

Summary

This is a crossectional study that will be conducted at several tertiary centers in Greece.

To participate in the study, patients should be ≥18 years of age, fluent in Greek language, diagnosed with chronic HP, on optimal treatment with calcium and active vitamin D metabolites. Chronic HP is defined when continuous therapy with calcium and vitamin D is required for \>12 months.

Exclusion criteria will include:

1. Patients inadequately controlled with conventional therapy:

1. corrected serum Ca (cCa) ≤8 mg/dl or cCa ≤8.2 mg/dl with symptoms of hypocalcemia
2. serum P \>5.5 mg/dl
2. Age \>80 years
3. Presence of neoplastic disease
4. Pregnancy
5. Diagnosis of psychiatric disease or cognitive impairment
6. Participants experiencing other comorbidities that may affect QoL
7. Lack of informed consent The study will seek approval from the Ethics in Research Committee of its participating center. All participants will be informed about the objectives of the study and will sign an informed consent.

The HPES-Symptom was developed in accordance with the Food and Drug Administration guidance and best research practices for PRO measure development. The methodology used has been previously described.

The first step of the translation process requires two forward translations of the English version of the questionnaire. The translations will be done by two translators who are native speakers of the target (Greek) language and can understand the English version. Then a reconciled translation is made based on the two translations - that is, the chief investigator will review the two translations to achieve the best possible version by choosing one of the two translations or by combining them on the basis of their correctness, wording etc.

The next step requires translating the reconciled version back into English, again done by two translators who will be native speakers of English or at least will have a very good command of English.

Conditions

  • Hypoparathyroidism

Interventions

OTHER

Questionnaire and Physical Exam

Translation and validation of the existing HPES-Symptom and HPES-Impact Questionnaires in the Greek population

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    collaborator OTHER
  • 424 General Military Hospital

    collaborator OTHER
  • General Hospital Of Thessaloniki Ippokratio

    collaborator OTHER
  • Laikο General Hospital, Athens

    collaborator OTHER
  • 251 Hellenic Air Force & VA General Hospital

    collaborator OTHER
  • Hellenic Red Cross Hospital

    collaborator OTHER
  • Aristotle University Of Thessaloniki

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-04-30
Completion
2026-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07160348 on ClinicalTrials.gov